UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study

Arthritis care & research (2010), 2016-04, Vol.68 (4), p.534-543

2016

Volltextzugriff (PDF)

FRI0002 Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Cynomolgus Monkeys and in Patients with Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.420-420

2015

Volltextzugriff (PDF)

THU0023 Correlation of Laboratory and Clinical Parameters with British Isles Lupus Assessment Group Response in an Open-Label Extension Study of Epratuzumab in Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.184-184

2014

Volltextzugriff (PDF)

THU0286 Immunologic Response to Long-Term Epratuzumab Treatment in Sl0008, An Open-Label Long-Term Extension Study in Patients with Moderate-to-Severe Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A262-A263

2013

Volltextzugriff (PDF)

THU0272 Epratuzumab Maintains Improvements in Disease Activity for Over 2 Years in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A257-A257

2013

Volltextzugriff (PDF)

THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A259-A259

2013

Volltextzugriff (PDF)

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.183-190

2014

Volltextzugriff (PDF)

Low-carbon land transport: policy handbook

Bongardt, Daniel

1st ed., 2013

Volltextzugriff (PDF)

(183) Evaluation of lacosamide in diabetic neuropathic pain trials

The journal of pain, 2008, Vol.9 (4), p.21-21

2008

Volltextzugriff (PDF)

177 A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy

European journal of pain, 2007-06, Vol.11 (1), p.77-78

2007

Volltextzugriff (PDF)

(204) Long-term efficacy of lacosamide in subjects with painful distal diabetic neuropathy

The journal of pain, 2008, Vol.9 (4), p.27-27

2008

Volltextzugriff (PDF)

Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens

The Clinical journal of pain, 2009-06, Vol.25 (5), p.376-385

2009

Volltextzugriff (PDF)

Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial

The journal of pain, 2009-08, Vol.10 (8), p.818-828

2009

Volltextzugriff (PDF)

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy

Diabetes care, 2010-04, Vol.33 (4), p.839-841

2010

Volltextzugriff (PDF)

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

The New England journal of medicine, 2023-10, Vol.389 (14), p.1298-1309

2023

Volltextzugriff (PDF)

Romantic Relationships and Sexuality in Adolescence and Young Adulthood: The Role of Parents, Peers and Partners

2017

Volltextzugriff (PDF)

Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update

Journal of rheumatology, 2011-07, Vol.38 (7), p.1487

2011

Volltextzugriff (PDF)

(766): A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy

The journal of pain, 2006-04, Vol.7 (4), p.S43-S43

2006

Volltextzugriff (PDF)

766

The journal of pain, 2006-04, Vol.7 (4), p.S43

2006

Volltextzugriff (PDF)

638 LACOSAMIDE IN PATIENTS WITH PAINFUL DIABETIC NEUROPATHY: 1 YEAR INTERIM RESULTS FROM A LONG-TERM, MULTI-CENTER, OPEN-LABEL TRIAL

European journal of pain, 2006-09, Vol.10 (S1), p.S167a-S167

2006

Volltextzugriff (PDF)

637 LACOSAMIDE IN PAINFUL DISTAL DIABETIC NEUROPATHY: RESULTS OF A MULTI-CENTER, PLACEBO-CONTROLLED US TRIAL

European journal of pain, 2006-09, Vol.10 (S1), p.S167-S167

2006

Volltextzugriff (PDF)

1053

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S160

2006

Volltextzugriff (PDF)

1053: Distribution of Sentinel Lymph Nodes in Patients With Cervical Cancer- Implications for Target Volumes in Radiation Therapy?

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S160-S160

2006

Volltextzugriff (PDF)

Sentinellymphnodektomie beim Zervixkarzinom

Der Onkologe, 2006-09, Vol.12 (9), p.888-894

2006

Volltextzugriff (PDF)

Adolescents’ use of affiliative and aggressive strategies during conflict with romantic partners and best-friends

Romantic Relationships and Sexuality in Adolescence and Young Adulthood, 2017, p.65-80

2017

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(204)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study

FRI0002 Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Cynomolgus Monkeys and in Patients with Systemic Lupus Erythematosus

THU0023 Correlation of Laboratory and Clinical Parameters with British Isles Lupus Assessment Group Response in an Open-Label Extension Study of Epratuzumab in Systemic Lupus Erythematosus

THU0286 Immunologic Response to Long-Term Epratuzumab Treatment in Sl0008, An Open-Label Long-Term Extension Study in Patients with Moderate-to-Severe Systemic Lupus Erythematosus

THU0272 Epratuzumab Maintains Improvements in Disease Activity for Over 2 Years in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

Low-carbon land transport: policy handbook

(183) Evaluation of lacosamide in diabetic neuropathic pain trials

177 A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy

(204) Long-term efficacy of lacosamide in subjects with painful distal diabetic neuropathy

Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens

Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

Romantic Relationships and Sexuality in Adolescence and Young Adulthood: The Role of Parents, Peers and Partners

Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update

(766): A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy

766

638 LACOSAMIDE IN PATIENTS WITH PAINFUL DIABETIC NEUROPATHY: 1 YEAR INTERIM RESULTS FROM A LONG-TERM, MULTI-CENTER, OPEN-LABEL TRIAL

637 LACOSAMIDE IN PAINFUL DISTAL DIABETIC NEUROPATHY: RESULTS OF A MULTI-CENTER, PLACEBO-CONTROLLED US TRIAL

1053

1053: Distribution of Sentinel Lymph Nodes in Patients With Cervical Cancer- Implications for Target Volumes in Radiation Therapy?

Sentinellymphnodektomie beim Zervixkarzinom

Adolescents’ use of affiliative and aggressive strategies during conflict with romantic partners and best-friends

Suchergebnisse filtern